Shigeru Marubashi
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis 71
- Liver Disease and Transplantation 39
- Cancer Research top 1%
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 57
- Surgery top 1%
- Organ Transplantation Techniques and Outcomes 51
- Cholangiocarcinoma and Gallbladder Cancer Studies 50
- Transplantation top 5%
-
- Liver Disease Diagnosis and Treatment 30
-
- Gallbladder and Bile Duct Disorders 23
- Gastric Cancer Management and Outcomes 20
- Co-authors
- Hiroaki NaganoHiroshi WadaKoji UmeshitaShogo KobayashiYuichiro� DokiHidetoshi EguchiYutaka TakedaMasaki Mori
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (3 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Shigeru Marubashi
258 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 114
- Hepatology 2.0k
- Cancer Research 1.4k
- Oncology 2.1k
- Surgery 2.6k
- Transplantation 122
Countries citing papers authored by Shigeru Marubashi
This map shows the geographic impact of Shigeru Marubashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Marubashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Marubashi more than expected).
Fields of papers citing papers by Shigeru Marubashi
This network shows the impact of papers produced by Shigeru Marubashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Marubashi. The network helps show where Shigeru Marubashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shigeru Marubashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 5 | |
| 6 | [FOLFIRINOX for Locally Advanced and Recurrent Pancreatic Cancer with UGT1A1 *6 and or UGT1A1*28 Polymorphisms-A Report of Two Cases]. | 2019 | 0 |
| 7 | 2016 | 58 | |
| 8 | 2016 | 1 | |
| 9 | 2015 | 8 | |
| 10 | 2014 | 2 | |
| 11 | 2014 | 16 | |
| 12 | 2010 | 50 | |
| 13 | 2010 | 1 | |
| 14 | 2010 | 32 | |
| 15 | 2009 | 21 | |
| 16 | 2009 | 27 | |
| 17 | 2009 | 13 | |
| 18 | 2008 | 34 | |
| 19 | 2007 | 25 | |
| 20 | 2006 | 22 |
About Shigeru Marubashi
Shigeru Marubashi is a scholar working on Hepatology, Transplantation and Oncology, having authored 269 papers that have together received 6.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (71 papers), Pancreatic and Hepatic Oncology Research (57 papers), Organ Transplantation Techniques and Outcomes (51 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (50 papers), Liver Disease and Transplantation (39 papers), Liver Disease Diagnosis and Treatment (30 papers), Gallbladder and Bile Duct Disorders (23 papers) and Gastric Cancer Management and Outcomes (20 papers). The work is most often cited by research in Hepatology (2.0k citations), Cancer Research (1.4k citations) and Oncology (2.1k citations). Shigeru Marubashi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hiroaki Nagano, Hiroshi Wada, Koji Umeshita, Shogo Kobayashi, Yuichiro� Doki, Hidetoshi Eguchi, Yutaka Takeda, Masaki Mori, Morito Monden and Keizo Dono. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.